Thiazole derivatives as NPY receptor antagonists

Details for Australian Patent Application No. 2003210305 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Nettekoven, Matthias Heinrich; Mattei, Patrizio; Taylor, Sven; Neidhart, Werner; Pflieger, Philippe

Agent Spruson & Ferguson

Pub. Number AU-B-2003210305

PCT Number PCT/EP03/01667

PCT Pub. Number WO2003/072577

Priority 02004296.6 28.02.02 EP

Filing date 19 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 6 July 2006

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 02004296.6 28.02.02 EP

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003210305

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003210305

6 July 2006 Application Accepted

  Published as AU-B-2003210305

2 November 2006 Standard Patent Sealed

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210306-Tissue specific expression

2003210304-METHOD FOR PACKING CIGARETTES AND CIGARETTE PACKAGING